Mercado de dispositivos de administración de medicamentos sin agujas: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPHE100001168
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Buy Now

RESUMEN DEL MERCADO

Los sistemas de administración de medicamentos sin agujas son una forma y un método innovadores de administración de medicamentos y otros tipos de medicamentos. También pueden ser parches transdérmicos, sistemas de inhalación o incluso microagujas que no perforan la piel como una aguja convencional. Los pacientes con diabetes tipo 1 requieren un control regular de la glucosa y el uso de agujas para la administración de insulina, lo que aumenta el riesgo de infección y dolor entre las personas. Los dispositivos sin agujas proporcionan un parto menos doloroso y reducen el riesgo de infección. Como resultado, se espera que la demanda de estos dispositivos aumente durante el período de pronóstico.

ÁMBITO DEL MERCADO

El "Análisis del mercado global de dispositivos de administración de medicamentos sin agujas hasta 2028" es un estudio especializado y en profundidad de la industria de alimentos y bebidas con especial enfoque en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado de dispositivos de administración de medicamentos sin agujas con una segmentación detallada del mercado por técnica, aplicación y geografía. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado de Dispositivos de administración de medicamentos sin agujas y ofrece tendencias y oportunidades clave en el mercado.

SEGMENTACIÓN DEL MERCADO

    •  Según la técnica, el mercado global de dispositivos de administración de medicamentos sin agujas se segmenta en inhaladores, parches transdérmicos, inyectores de chorro y novedosos sin agujas. •  Según la aplicación, el mercado se segmenta en inyección pediátrica, dispositivos de administración de insulina, dispositivos de administración de vacunas y otros.

DINÁMICA DEL MERCADO

Impulsores

    •  Aumento de la prevalencia de diabetes y enfermedades crónicas. •  Creciente demanda de entrega de medicamentos sin dolor. •  Avance tecnológico en dispositivos de administración de medicamentos.

Restricciones

    •  Alto costo de estos dispositivos y estricto proceso de aprobación regulatoria.

MARCO REGIONAL

El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y una previsión del mercado global en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico del año 2019 al 2028 con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur. El mercado de dispositivos de administración de medicamentos sin agujas de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y pronóstico de 18 países a nivel mundial junto con la tendencia actual y las oportunidades que prevalecen en la región. El informe analiza los factores que afectan al mercado tanto desde el lado de la demanda como de la oferta y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y América del Sur después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de dispositivos de administración de medicamentos sin agujas en estas regiones.

IMPACTO DEL COVID-19 EN EL MERCADO DE DISPOSITIVOS DE SUMINISTRO DE MEDICAMENTOS SIN AGUJA

Actualmente existen múltiples programas de desarrollo de vacunas contra el COVID 19 en ejecución en todo el mundo. Es de esperar que algunos de estos sean aprobados para su uso en breve y tengan un impacto importante. Paralelamente, los gobiernos y fuentes sin fines de lucro están realizando importantes inversiones para crear la capacidad adecuada para la entrega y administración de dichas vacunas a escala nacional y mundial. Se espera que aumente la demanda de dispositivos de administración de medicamentos sin agujas para la administración de vacunas, ya que estos dispositivos no presentan riesgos, son seguros y eficaces. Por ejemplo, en octubre de 2020, la FDA de EE. UU. otorgó la autorización de comercialización 510(k) para los sistemas de inyección sin aguja desarrollados por PharmaJet para el ensayo de una vacuna candidata contra la COVID-19.

JUGADORES DEL MERCADO

El informe cubre desarrollos clave en el mercado de dispositivos de administración de medicamentos sin agujas como estrategias de crecimiento orgánico e inorgánico. Varias empresas se están centrando en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las actividades de estrategias de crecimiento inorgánico observadas en el mercado fueron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de los negocios y la base de clientes de los actores del mercado. Se prevé que los contribuyentes del mercado de dispositivos de administración de medicamentos sin agujas tendrán oportunidades de crecimiento lucrativas en el futuro con la creciente demanda de dispositivos de administración de medicamentos sin agujas en el mercado global. El informe también incluye los perfiles de empresas clave junto con su análisis FODA y estrategias de mercado en el mercado de dispositivos de administración de medicamentos sin agujas. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años, el desarrollo clave en los últimos cinco años.
    •  Antares Pharma, Inc. •  Endo Internacional plc. •  PharmaJet •  Bioject Medical Technologies Inc. •  Tecnología médica internacional, Inc. •  INJEX Pharma AG •  Productos Médicos Nacionales Inc. •  Valeritas, Inc. •  Grupo farmacéutico europeo •  PenJet Corporation
El equipo dedicado de investigación y análisis de Insight Partner está formado por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el estudio existente.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is needle-free drug delivery device?

Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.

What are the driving and restraining factors for the needle-free drug delivery device market?

Increasing prevalence of chronic diseases and increasing needlestick injuries propels the needle-free drug delivery devices market growth. However, the high cost of development as compare to injections hinders the growth of the market.

Who are the major players in market the needle-free drug delivery device market?

The needle-free drug delivery device market majorly consists of the players such NuGen Medical Devices Inc, NovaXS Biotech, GlaxoSmithKline, AstraZeneca, Roche, Boehringer Ingelheim, Merck, Cipla, Novartis, Teva Pharmaceuticals, Omron Healthcare, Sumitomo Pharma Co., Ltd

Which segment is dominating the needle-free drug delivery device market?

Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others.
By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.

Which region is dominating the needle-free drug delivery device market?

Based on geography, the needle-free drug delivery device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global needle-free drug delivery device market. Asia Pacific is expected to register the highest CAGR in the needle-free drug delivery device market during 2022–2030.

The List of Companies - Needle-Free Drug Delivery Devices Market 

  1. NuGen Medical Devices Inc
  2. NovaXS Biotech
  3. GlaxoSmithKline
  4. AstraZeneca
  5. Roche
  6. Boehringer Ingelheim
  7. Merck
  8. Cipla
  9. Novartis
  10. Teva Pharmaceuticals
  11. Omron Healthcare
  12. Sumitomo Pharma Co., Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports